Maureen Cronin

Summary

Publications

  1. pmc Biomarker discovery for colon cancer using a 761 gene RT-PCR assay
    Kim M Clark-Langone
    Genomic Health, Inc, Redwood City, CA, USA
    BMC Genomics 8:279. 2007
  2. ncbi request reprint Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
    Maureen Cronin
    Genomic Health, Inc, Redwood City, CA 94063, USA
    Clin Chem 53:1084-91. 2007
  3. pmc Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay
    Maureen Cronin
    Genomic Health Incorporated, Redwood City, California 94063, USA
    Am J Pathol 164:35-42. 2004
  4. ncbi request reprint Universal RNA reference materials for gene expression
    Maureen Cronin
    Genomic Health, Inc, Redwood City, CA, USA
    Clin Chem 50:1464-71. 2004
  5. ncbi request reprint Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
    Francisco J Esteva
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 11:3315-9. 2005
  6. ncbi request reprint Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
    Luca Gianni
    Medical Oncology, Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milano, Italy
    J Clin Oncol 23:7265-77. 2005
  7. ncbi request reprint A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    Soonmyung Paik
    Division of Pathology, Operation Center, and the Biostatistics Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh 15212, USA
    N Engl J Med 351:2817-26. 2004
  8. ncbi request reprint Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    Soonmyung Paik
    Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 24:3726-34. 2006
  9. ncbi request reprint Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes
    Melody A Cobleigh
    Rush University Medical Center, Chicago, Illinois 60612, USA
    Clin Cancer Res 11:8623-31. 2005
  10. ncbi request reprint Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue
    Lida Mina
    Department of Medicine, Indiana University, RT 473, Indianapolis, IN, 46202, USA
    Breast Cancer Res Treat 103:197-208. 2007

Detail Information

Publications10

  1. pmc Biomarker discovery for colon cancer using a 761 gene RT-PCR assay
    Kim M Clark-Langone
    Genomic Health, Inc, Redwood City, CA, USA
    BMC Genomics 8:279. 2007
    ..This screening strategy remains attractive due to the inherent advantages of maintaining platform consistency from discovery through clinical application...
  2. ncbi request reprint Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
    Maureen Cronin
    Genomic Health, Inc, Redwood City, CA 94063, USA
    Clin Chem 53:1084-91. 2007
    ..Individualized patient management requires strict performance criteria for clinical laboratory tests. We therefore investigated the analytical performance of the assay...
  3. pmc Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay
    Maureen Cronin
    Genomic Health Incorporated, Redwood City, California 94063, USA
    Am J Pathol 164:35-42. 2004
    ..These findings support the development of RT-PCR analysis of FPE tissue RNA as a platform for multianalyte clinical diagnostic tests...
  4. ncbi request reprint Universal RNA reference materials for gene expression
    Maureen Cronin
    Genomic Health, Inc, Redwood City, CA, USA
    Clin Chem 50:1464-71. 2004
    ..Work is underway at NIST and among members of the gene expression array community to further define these materials and make them available...
  5. ncbi request reprint Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
    Francisco J Esteva
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 11:3315-9. 2005
    ..A secondary objective was to determine whether the quantitative RT-PCR data correlated with immunohistochemistry assay data regarding estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status...
  6. ncbi request reprint Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
    Luca Gianni
    Medical Oncology, Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milano, Italy
    J Clin Oncol 23:7265-77. 2005
    ..We sought to identify gene expression markers that predict the likelihood of chemotherapy response. We also tested whether chemotherapy response is correlated with the 21-gene Recurrence Score assay that quantifies recurrence risk...
  7. ncbi request reprint A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    Soonmyung Paik
    Division of Pathology, Operation Center, and the Biostatistics Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh 15212, USA
    N Engl J Med 351:2817-26. 2004
    ..The likelihood of distant recurrence in patients with breast cancer who have no involved lymph nodes and estrogen-receptor-positive tumors is poorly defined by clinical and histopathological measures...
  8. ncbi request reprint Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    Soonmyung Paik
    Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 24:3726-34. 2006
    ..The relationship between the RS and chemotherapy benefit is not known...
  9. ncbi request reprint Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes
    Melody A Cobleigh
    Rush University Medical Center, Chicago, Illinois 60612, USA
    Clin Cancer Res 11:8623-31. 2005
    ....
  10. ncbi request reprint Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue
    Lida Mina
    Department of Medicine, Indiana University, RT 473, Indianapolis, IN, 46202, USA
    Breast Cancer Res Treat 103:197-208. 2007
    ..We used paraffin-embedded core biopsies from a completed phase II trial to identify genes that correlate with response to primary chemotherapy...